Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression
Author:
Funder
Natural Science Foundation of Hubei Province
Wuhan University
Publisher
Elsevier BV
Subject
Cell Biology
Reference34 articles.
1. New therapies for hepatocellular carcinoma;Avila;Oncogene.,2006
2. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology.,2007
3. Recent advances in the treatment of hepatocellular carcinoma;Singal;Curr. Opin. Gastroenterol.,2010
4. Surgical resection and liver transplantation for hepatocellular carcinoma;Akoad;Clinics in Liver Disease.,2015
5. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets;Boyault;Hepatology.,2007
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances on Senescence-associated secretory phenotype regulated by circular RNAs in tumors;Ageing Research Reviews;2024-06
2. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors;The International Journal of Biochemistry & Cell Biology;2024-05
3. Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors;Journal of Cancer Research and Clinical Oncology;2024-04-30
4. CircSNX6 promotes proliferation, metastasis, and angiogenesis in hepatocellular carcinoma via miR-383-5p/VEGFA signaling pathway;Scientific Reports;2024-04-08
5. Hsa_circ_0010882 facilitates hepatocellular carcinoma progression by modulating M1/M2 macrophage polarization;Journal of Viral Hepatitis;2024-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3